ROCKVILLE, Md.--(BUSINESS WIRE)--BioReliance Corporation announced today Darryl L. Goss has been appointed Vice President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly formed Business Unit. Goss, who was previously Vice President, Global Process Excellence at BioReliance, will continue to serve on the company’s Operating Committee and report to David A. Dodd, President, CEO and Chairman, BioReliance Corporation.
